These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 12389086)

  • 1. Cyclosporin A-related Raynaud's phenomenon in a renal transplant recipient.
    Sharma AK; Sunil S; Rustom R; Bone JM; Hammad A; Bakran A; Sells RA
    Transpl Int; 2002 Oct; 15(9-10):517-8. PubMed ID: 12389086
    [No Abstract]   [Full Text] [Related]  

  • 2. Cyclosporin conversion to CellCept in a cadaveric renal allograft recipient with hemolytic uremic syndrome.
    Said T; al-Mousawi M; Samhan M; Lao M
    Transplant Proc; 1999 Dec; 31(8):3295-7. PubMed ID: 10616482
    [No Abstract]   [Full Text] [Related]  

  • 3. Cyclosporine--a treatment and a rare complication: Raynaud's phenomenon.
    Arinsoy T; Derici U; Yuksel A; Reis KA; Sindel S
    Int J Clin Pract; 2005 Jul; 59(7):863-4. PubMed ID: 15963220
    [No Abstract]   [Full Text] [Related]  

  • 4. Use of mycophenolate mofetil in renal transplant patients with cyclosporin toxicity.
    Shaheen FA; Sheikh IA
    Transplant Proc; 1999 Dec; 31(8):3294. PubMed ID: 10616481
    [No Abstract]   [Full Text] [Related]  

  • 5. Cytomegalovirus colitis in a CMV-seropositive renal transplant recipient on triple drug therapy (including mycophenolate).
    Smak Gregoor PJ; van Gelder T; Abraham Tanis A; Chadha-Ajwani S; Klaassen RJ; Weimar W
    Nephrol Dial Transplant; 1997 Dec; 12(12):2766-7. PubMed ID: 9430894
    [No Abstract]   [Full Text] [Related]  

  • 6. Mycophenolate mofetil in cyclosporin-associated thrombotic microangiopathy.
    Lecornu-Heuze L; Ducloux D; Rebibou JM; Martin L; Billerey C; Chalopin JM
    Nephrol Dial Transplant; 1998 Dec; 13(12):3212-3. PubMed ID: 9870494
    [No Abstract]   [Full Text] [Related]  

  • 7. Cyclosporine and sirolimus interaction in a kidney transplant patient.
    Dabrowska-Zamojcin E; Pawlik A; Domański L; Rózański J; Droździk M
    Transplant Proc; 2005 Jun; 37(5):2317-9. PubMed ID: 15964407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective study of lipid disorders in FK506-versus cyclosporine-treated renal transplant patients.
    Vela CG; Cristol JP; Descomps B; Mourad G
    Transplant Proc; 2000 Mar; 32(2):398. PubMed ID: 10715453
    [No Abstract]   [Full Text] [Related]  

  • 9. Controlled trial of RS-61443 in renal transplant patients receiving cyclosporine monotherapy.
    Salaman JR; Griffin PJ; Johnson RW; Kohlhaw K; Land W; Moore R; Pichlmayr R; Sells R
    Transplant Proc; 1993 Feb; 25(1 Pt 1):695-6. PubMed ID: 8438441
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hemolytic anemia caused by graft-versus-host reaction in ABO-nonidentical renal transplants from blood group O donors].
    Peces R; Díaz Corte C; Navascués RA
    Nefrologia; 2001; 21(4):395-401. PubMed ID: 11816517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclosporine as a cause of unilateral gynecomastia in renal transplant recipient.
    Kumar A; Bansal V; Mehra S; Minz M; Sharma AK
    J Assoc Physicians India; 1999 Jul; 47(7):746. PubMed ID: 10778606
    [No Abstract]   [Full Text] [Related]  

  • 12. [Factors influencing prevalence and clinical course of cytomegalovirus (CMV) infection in kidney transplant patients].
    Szymczakiewicz-Multanowska AM; Kuźniewski M; Zawilińska B; Zgórniak-Nowosielska I; Uracz D; Ignacak E; Betkowska-Prokop A; Sułowicz W
    Przegl Lek; 2001; 58(7-8):772-7. PubMed ID: 11769385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mycophenolate mofetil].
    Abramowicz D; Broeders N; Wissing M; Sternon J
    Rev Med Brux; 1998 Jun; 19(3):139-43. PubMed ID: 9697397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kidney graft dysfunction after drug interaction between miocamycin and cyclosporin.
    Treille S; Quoidbach A; Demol H; Juvenois A; Dehout F; Abramowicz D
    Transpl Int; 1999; 12(2):157. PubMed ID: 10363601
    [No Abstract]   [Full Text] [Related]  

  • 15. Hyperlipidaemia and post-heparin lipase activities in renal transplant recipients treated with sirolimus or cyclosporin A.
    Massy ZA; De Bandt JP; Morelon E; Thevenin M; Lacour B; Kreis H
    Nephrol Dial Transplant; 2000 Jun; 15(6):928. PubMed ID: 10831671
    [No Abstract]   [Full Text] [Related]  

  • 16. Tacrolimus-associated severe bilateral corneal ulcer after renal transplantation.
    Lauzurica R; Loscos J; Diaz-Couchod P; Bayés B; de la Camara J
    Transplantation; 2002 Mar; 73(6):1006-7. PubMed ID: 11923710
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of immunosuppression on damage, leukocyte infiltration, and regeneration after severe warm ischemia/reperfusion renal injury.
    De Greef KE; Ysebaert DK; Vercauteren SR; Chapelle T; Roeyen G; Bosmans JL; Verpooten GA; De Broe ME
    Transplant Proc; 2002 May; 34(3):791-4. PubMed ID: 12034184
    [No Abstract]   [Full Text] [Related]  

  • 18. Cyclosporine-associated encephalopathy: a case report and literature review.
    Chang SH; Lim CS; Low TS; Chong HT; Tan SY
    Transplant Proc; 2001; 33(7-8):3700-1. PubMed ID: 11750577
    [No Abstract]   [Full Text] [Related]  

  • 19. Myalgia: an uncommon or underestimated side effect of mycophenolate mophetil after transplantation?
    Piccoli GB; Rossetti M; Guarena C; Consiglio V; Mezza E; Soragna G; Grassi G; Burdese M; Gai M; Marchetti P; Boggi U; Segoloni GP
    Nephrol Dial Transplant; 2004 Jul; 19(7):1940-2. PubMed ID: 15199214
    [No Abstract]   [Full Text] [Related]  

  • 20. [Hair-like hyperkeratoses in patients with kidney transplants. A new cyclosporin side-effect].
    Izakovic J; Büchner SA; Düggelin M; Guggenheim R; Itin PH
    Hautarzt; 1995 Dec; 46(12):841-6. PubMed ID: 8567267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.